A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants
Clinical trial NCT04839809 · COMPLETED
Trial details
- NCT number
- NCT04839809
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-19
- Primary completion
- 2021-10-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.